Rodríguez-Angarita Carlos Edgardo, Sanabria-Arenas Rafael Mauricio, Vargas-Jaramillo Juan Diego, Ronderos-Botero Izcay
Research Group in Neurology and Psychiatry (INEUROPSI), Fundación Universitaria de Ciencias de la Salud (FUCS), Carrera 19 No 8A-32, Bogotá, D.C., Colombia.
Renal Teraphy Services (RTS), Bogotá, D.C., Colombia.
Can J Kidney Health Dis. 2016 May 10;3:26. doi: 10.1186/s40697-016-0116-7. eCollection 2016.
Growth of the elderly population is linked to the increase of comorbid conditions such as chronic kidney disease (CKD), depression, and cognitive impairment (CI). Cognitive impairment can vary from minimal deficits in the normal aging, to mild cognitive impairment with a prevalence ranging from 1 to 29 % in people ≥ 65 years of age, up to severe impairment with a prevalence of 6 to 42 %. The CI induced by depression usually affects the functional performance of the elderly.
The objective of the study is to describe the prevalence of CI and depression in patients ≥ 55 years with CKD stages 3 and 4, attending a secondary prevention program during 2012-2013.
The design of the study is a cross-sectional study of simple random sampling, and 308 patients were invited to participate.
Patients were being treated in a CKD secondary prevention program in Bogotá, Colombia, during 2012-2013.
Participants were over 54 years diagnosed with CKD in stages 3 to 4 according to the K/DOQI classification.
CI was assessed using NEUROPSI and modified Lawton Scale; depression was measured with Yesavage Geriatric Depression Scale and the MINI International Neuropsychiatric Interview.
Through an interview with the subjects, information regarding age, occupation, civil status, educational level, and clinical baseline variables was collected. Clinical assessment with specific instruments was performed by a multidisciplinary team composed of nephrologists, a psychiatrist, a neurologist, and a neuropsychologist.
Two hundred and fifty-one patients agreed to participate. The average age was 76.3 (SD = 7.9) years, 67 % were males, and 86.5 % had CKD stage 3. Overall prevalence of CI was 51 % (95 % CI 44.7 to 57.2), and the prevalence of major depression reached 8 % (95 % CI 4.5 to 11.3); 4.8 % of the patients (n = 12) had both CI and depression.
A limitation of the study is its design, which does not allow establishing the direction of the association between predictors and outcomes. Suggested associations must be interpreted cautiously as they are generated as hypothesis, which should be investigated in properly designed trials.
CI and depression are prevalent conditions among patients with CKD stages 3-4, with the greatest occurrence of CI, affecting half of the investigated Colombian patients with age ≥ 55 years.
老年人口的增长与慢性肾脏病(CKD)、抑郁症和认知障碍(CI)等合并症的增加有关。认知障碍的程度各异,从正常衰老过程中的轻微缺陷,到65岁及以上人群中患病率为1%至29%的轻度认知障碍,再到患病率为6%至42%的重度认知障碍。抑郁症所致的认知障碍通常会影响老年人的功能表现。
本研究的目的是描述2012 - 2013年期间参加二级预防项目的年龄≥55岁的3 - 4期CKD患者中认知障碍和抑郁症的患病率。
本研究采用简单随机抽样的横断面研究设计,邀请了308名患者参与。
2012 - 2013年期间,患者在哥伦比亚波哥大的一个CKD二级预防项目中接受治疗。
参与者为根据K/DOQI分类被诊断为3 - 4期CKD的54岁以上患者。
使用NEUROPSI和改良的Lawton量表评估认知障碍;使用Yesavage老年抑郁量表和MINI国际神经精神访谈量表测量抑郁症。
通过与受试者访谈,收集有关年龄、职业、婚姻状况、教育水平和临床基线变量的信息。由肾病学家、精神科医生、神经科医生和神经心理学家组成的多学科团队使用特定工具进行临床评估。
251名患者同意参与。平均年龄为76.3(标准差 = 7.9)岁,67%为男性,86.5%患有3期CKD。认知障碍的总体患病率为51%(95%置信区间44.7至57.2),重度抑郁症的患病率达8%(95%置信区间4.5至11.3);4.8%的患者(n = 12)同时患有认知障碍和抑郁症。
本研究的一个局限性在于其设计,该设计无法确定预测因素与结果之间关联的方向。所提示的关联必须谨慎解释,因为它们是作为假设产生的,应在设计合理的试验中进行研究。
认知障碍和抑郁症在3 - 4期CKD患者中普遍存在,其中认知障碍最为常见,影响了一半年龄≥55岁的哥伦比亚受试患者。